Gene: LAMC2
Official Full Name: laminin subunit gamma 2provided by HGNC
Gene Summary: Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), have a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 2. The gamma 2 chain, formerly thought to be a truncated version of beta chain (B2t), is highly homologous to the gamma 1 chain; however, it lacks domain VI, and domains V, IV and III are shorter. It is expressed in several fetal tissues but differently from gamma 1, and is specifically localized to epithelial cells in skin, lung and kidney. The gamma 2 chain together with alpha 3 and beta 3 chains constitute laminin 5 (earlier known as kalinin), which is an integral part of the anchoring filaments that connect epithelial cells to the underlying basement membrane. The epithelium-specific expression of the gamma 2 chain implied its role as an epithelium attachment molecule, and mutations in this gene have been associated with junctional epidermolysis bullosa, a skin disease characterized by blisters due to disruption of the epidermal-dermal junction. Two transcript variants resulting from alternative splicing of the 3' terminal exon, and encoding different isoforms of gamma 2 chain, have been described. The two variants are differentially expressed in embryonic tissues, however, the biological significance of the two forms is not known. Transcript variants utilizing alternative polyA_signal have also been noted in literature. [provided by RefSeq, Aug 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10244 | LAMC2 Knockout cell line (HeLa) | Human | LAMC2 | 1:3~1:6 | Negative | Online Inquiry |
KO10245 | LAMC2 Knockout cell line (HCT 116) | Human | LAMC2 | 1:2~1:4 | Negative | Online Inquiry |
KO10246 | LAMC2 Knockout cell line (A549) | Human | LAMC2 | 1:3~1:4 | Negative | Online Inquiry |
LAMC2 Gene Knockout Cell Lines are engineered cellular models that have been meticulously designed to lack the expression of the LAMC2 gene, which encodes the laminin gamma-2 chain, a crucial component of the extracellular matrix. This gene's disruption creates a unique platform for investigating the biological roles of laminins in cell adhesion, migration, and tissue organization.
These cell lines function by eliminating the pathways associated with LAMC2, allowing researchers to study its effects on cellular behavior, signal transduction, and interactions with various growth factors. By observing the changes in these knockout models, scientists can elucidate the gene's contributions to pathological processes such as cancer metastasis or developmental disorders. The use of LAMC2 knockout cell lines is particularly significant in preclinical research and drug development, as they provide insights into the molecular mechanisms underlying specific diseases.
What sets our LAMC2 Gene Knockout Cell Lines apart is their validated performance and robustness compared to other available models. They have been rigorously characterized in terms of gene deletion specificity, cellular morphology, and functional assays, ensuring reliability for downstream applications. This high level of characterization translates to increased confidence in experimental outcomes, making them an invaluable asset for researchers striving for reproducibility.
For researchers, clinicians, and biopharmaceutical companies, the LAMC2 knockout models represent a transformative tool that goes beyond traditional cell lines by providing a deeper understanding of disease mechanisms and potential therapeutic targets. Our commitment to advancing scientific research is reflected in our state-of-the-art manufacturing processes and the expertise of our team in genetic engineering, guaranteeing that you receive only the highest quality biological products tailored to your needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.